NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
iPS-technology and patient specific disease models
iPS-technology and patient specific disease models is a funding opportunity from NATIONAL HEART, LUNG, AND BLOOD INSTITUTE, up to 1537608.
Overview
The development and application of iPSC technology promises to revolutionize our understanding of disease mechanisms and improve the availability of treatment options. The ability to generate patient specific iPSC allows for the development of cell-based disease modeling where it has previously been extremely…